LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 79 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2019. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,633,000 | -25.3% | 825,481 | 0.0% | 0.00% | – |
| Q1 2022 | $3,525,000 | -8.6% | 825,481 | -0.5% | 0.00% | – |
| Q4 2021 | $3,857,000 | +8.6% | 829,443 | -6.8% | 0.00% | – |
| Q3 2021 | $3,551,000 | -6.2% | 889,902 | +0.6% | 0.00% | – |
| Q2 2021 | $3,785,000 | -8.8% | 884,225 | -9.7% | 0.00% | – |
| Q1 2021 | $4,150,000 | +2.0% | 978,854 | -6.6% | 0.00% | – |
| Q4 2020 | $4,069,000 | -5.3% | 1,048,421 | -1.7% | 0.00% | – |
| Q3 2020 | $4,296,000 | -0.3% | 1,066,181 | +5.3% | 0.00% | – |
| Q2 2020 | $4,311,000 | +1.0% | 1,012,304 | -0.4% | 0.00% | – |
| Q1 2020 | $4,267,000 | +5.7% | 1,015,886 | -1.1% | 0.00% | – |
| Q4 2019 | $4,037,000 | -55.4% | 1,027,344 | -0.1% | 0.00% | – |
| Q3 2019 | $9,053,000 | -6.4% | 1,028,781 | -1.6% | 0.00% | – |
| Q2 2019 | $9,669,000 | +45.5% | 1,045,292 | +1.2% | 0.00% | – |
| Q1 2019 | $6,644,000 | +14.6% | 1,033,195 | +68.0% | 0.00% | – |
| Q4 2018 | $5,799,000 | -70.6% | 615,022 | -37.3% | 0.00% | -100.0% |
| Q3 2018 | $19,735,000 | -30.2% | 980,336 | +1.1% | 0.00% | 0.0% |
| Q2 2018 | $28,273,000 | +2.3% | 969,253 | +4.5% | 0.00% | 0.0% |
| Q1 2018 | $27,631,000 | +7.1% | 927,869 | +15.7% | 0.00% | 0.0% |
| Q4 2017 | $25,808,000 | -6.8% | 802,012 | +0.7% | 0.00% | 0.0% |
| Q3 2017 | $27,686,000 | +13.9% | 796,064 | -2.5% | 0.00% | 0.0% |
| Q2 2017 | $24,316,000 | +23.0% | 816,779 | +23.3% | 0.00% | 0.0% |
| Q1 2017 | $19,769,000 | +115.2% | 662,285 | +26.4% | 0.00% | 0.0% |
| Q4 2016 | $9,188,000 | -23.6% | 524,130 | +3.6% | 0.00% | 0.0% |
| Q3 2016 | $12,030,000 | +55.3% | 505,704 | +4.5% | 0.00% | – |
| Q2 2016 | $7,745,000 | -22.1% | 484,062 | +1.8% | 0.00% | -100.0% |
| Q1 2016 | $9,940,000 | -19.4% | 475,375 | +4.1% | 0.00% | 0.0% |
| Q4 2015 | $12,330,000 | -48.7% | 456,684 | -47.2% | 0.00% | 0.0% |
| Q3 2015 | $24,022,000 | +159.2% | 864,404 | +128.6% | 0.00% | 0.0% |
| Q2 2015 | $9,269,000 | +44.6% | 378,167 | +8.0% | 0.00% | – |
| Q1 2015 | $6,410,000 | +6.2% | 350,270 | +7.0% | 0.00% | – |
| Q4 2014 | $6,038,000 | +97.7% | 327,244 | +3.0% | 0.00% | – |
| Q3 2014 | $3,054,000 | – | 317,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |